Table 2. Liver pathology score.
Parameter | BD | CTRL | PEMA-L | PEMA-H | FENO |
---|---|---|---|---|---|
n | 5 | 10 | 10 | 10 | 7 |
NAS | 0.2 ± 0.2† | 7.2 ± 0.2 | 6.2 ± 0.2 | 3.9 ± 0.5* | 5.7 ± 0.4* |
Steatosis | 0† | 3 | 3 | 1.3 ± 0.2* | 2.4 ± 0.2* |
Lobular inflammation | 0.2 ± 0.2† | 2.1 ± 0.2 | 1.2 ± 0.2 | 1.3 ± 0.4 | 1.4 ± 0.3 |
Hepatocyte ballooning | 0† | 2 | 2 | 1.3 ± 0.2* | 1.9 ± 0.1 |
Fibrosis | 0.4 ± 0.2† | 2.3 ± 0.2 | 1.6 ± 0.2 | 1.4 ± 0.2* | 1.3 ± 0.3* |
Nonalcoholic fatty liver disease activity score (NAS) and fibrosis stage were scored according to the method described by Kleiner et al.63, as outlined in (Supplementary Table 2). Significance was determined using Student’s t-test (†p < 0.05 versus CTRL mice) or Dunnett’s test (*p < 0.05 versus CTRL mice).